Physical frailty, genetic predisposition, and the risks of severe non-alcoholic fatty liver disease and cirrhosis: a cohort study

被引:0
作者
Yang, Honghao [1 ,2 ]
Ou, Fengrong [3 ]
Chang, Qing [1 ,2 ]
Jiang, Jinguo [1 ,2 ]
Liu, Yashu [1 ,2 ]
Ji, Chao [1 ,2 ]
Chen, Liangkai [4 ]
Xia, Yang [1 ,2 ]
Zhao, Yuhong [1 ,2 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Clin Epidemiol, 36 San Hao St, Shenyang 110004, Liaoning, Peoples R China
[2] Liaoning Key Lab Precis Med Res Major Chron Dis, Shenyang, Peoples R China
[3] China Med Univ, Sch Publ Hlth, Shenyang, Peoples R China
[4] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth,Tongji Med Coll, Wuhan, Peoples R China
关键词
Cirrhosis; Fatty liver; Frailty; Genetic predisposition; NAFLD; MECHANISMS;
D O I
10.1002/jcsm.13506
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundFrailty, defined as a phenotype of decreased physiological reserves and diminished ability to respond to stressors, has been linked to the development of chronic diseases. Epidemiological evidence connecting frailty to non-alcoholic fatty liver disease (NAFLD) and cirrhosis risks remain sparse. We aimed to assess the longitudinal associations of frailty with the risks of severe NAFLD and cirrhosis in middle-aged to older adults and further explore the modification role of genetic risk on these associations.MethodsThis study included a total of 398 386 participants from the UK Biobank. Incident cases of severe NAFLD and cirrhosis were ascertained through linked hospital records and death registries. Frailty status was assessed by a modified version of the frailty phenotype, encompassing five key components: weight loss, tiredness, physical activity, gait speed, and grip strength. Participants were classified as pre-frailty if they met one or two of these criteria, and as frailty if they met three or more. Genetic predisposition to NAFLD and cirrhosis was estimated by genetic risk score (GRS) and further categorized into high, intermediate, and low genetic risk levels according to tertiles of GRSs. Cox proportional hazards regression model was employed to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for their associations.ResultsThe mean (standard deviation) age of the study population was 56.6 (8.03) years. 214 408 (53.8%) of the participants was female; 14 924 (3.75%) of participants met the criteria for frailty, 170 498 (42.8%) for pre-frailty, and 212 964 (53.5%) for non-frailty. Over a median follow-up of 12.0 years, we documented 4439 incident severe NAFLD and 3323 incident cirrhosis cases, respectively. Compared with non-frailty, both pre-frailty (HR: 1.50; 95% CI: 1.40-1.60) and frailty (HR: 1.98; 95% CI: 1.77-2.21) were associated with increased risk of NAFLD. Similar associations were observed for cirrhosis, the corresponding HRs (95% CIs) for non-frailty, pre-frailty, and frailty were 1.00 (reference), 1.29 (1.20, 1.38), and 1.90 (1.66, 2.18). Such associations were consistent across all genetic risk levels, with no observed interactions between frailty and GRSs (all P for interactions >= 0.10). Compared with participants with frailty and a low level of genetic risk, the greatest risk increasement in developing severe NAFLD (HR: 3.36; 95% CI: 2.83-3.99) and cirrhosis (HR: 2.81; 95% CI: 2.29-3.44) was both observed in those with frailty and a high level of genetic risk.ConclusionsOur findings indicate that frailty is a significant predictor of severe NAFLD and cirrhosis, irrespective of genetic predisposition.
引用
收藏
页码:1491 / 1500
页数:10
相关论文
共 40 条
  • [1] A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
    Abul-Husn, N. S.
    Cheng, X.
    Li, A. H.
    Xin, Y.
    Schurmann, C.
    Stevis, P.
    Liu, Y.
    Kozlitina, J.
    Stender, S.
    Wood, G. C.
    Stepanchick, A. N.
    Still, M. D.
    McCarthy, S.
    O'Dushlaine, C.
    Packer, J. S.
    Balasubramanian, S.
    Gosalia, N.
    Esopi, D.
    Kim, S. Y.
    Mukherjee, S.
    Lopez, A. E.
    Fuller, E. D.
    Penn, J.
    Chu, X.
    Luo, J. Z.
    Mirshahi, U. L.
    Carey, D. J.
    Still, C. D.
    Feldman, M. D.
    Small, A.
    Damrauer, S. M.
    Rader, D. J.
    Zambrowicz, B.
    Olson, W.
    Murphy, A. J.
    Borecki, I. B.
    Shuldiner, A. R.
    Reid, J. G.
    Overton, J. D.
    Yancopoulos, G. D.
    Hobbs, H. H.
    Cohen, J. C.
    Gottesman, O.
    Teslovich, T. M.
    Baras, A.
    Mirshahi, T.
    Gromada, J.
    Dewey, F. E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) : 1096 - 1106
  • [3] Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
    Bianco, Cristiana
    Jamialahmadi, Oveis
    Pelusi, Serena
    Baselli, Guido
    Dongiovanni, Paola
    Zanoni, Irene
    Santoro, Luigi
    Maier, Silvia
    Liguori, Antonio
    Meroni, Marica
    Borroni, Vittorio
    D'Ambrosio, Roberta
    Spagnuolo, Rocco
    Alisi, Anna
    Federico, Alessandro
    Bugianesi, Elisabetta
    Petta, Salvatore
    Miele, Luca
    Vespasiani-Gentilucci, Umberto
    Anstee, Quentin M.
    Stickel, Felix
    Hampe, Jochen
    Fischer, Janett
    Berg, Thomas
    Fracanzani, Anna Ludovica
    Soardo, Giorgio
    Reeves, Helen
    Prati, Daniele
    Romeo, Stefano
    Valenti, Luca
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 775 - 782
  • [4] Neural mechanisms of ageing and cognitive decline
    Bishop, Nicholas A.
    Lu, Tao
    Yankner, Bruce A.
    [J]. NATURE, 2010, 464 (7288) : 529 - 535
  • [5] A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Bostroem, Pontus
    Wu, Jun
    Jedrychowski, Mark P.
    Korde, Anisha
    Ye, Li
    Lo, James C.
    Rasbach, Kyle A.
    Bostroem, Elisabeth Almer
    Choi, Jang Hyun
    Long, Jonathan Z.
    Kajimura, Shingo
    Zingaretti, Maria Cristina
    Vind, Birgitte F.
    Tu, Hua
    Cinti, Saverio
    Hojlund, Kurt
    Gygi, Steven P.
    Spiegelman, Bruce M.
    [J]. NATURE, 2012, 481 (7382) : 463 - U72
  • [6] Aptasensors Are Conjectured as Promising ALT and AST Diagnostic Tools for the Early Diagnosis of Acute Liver Injury
    Chinnappan, Raja
    Mir, Tanveer Ahmad
    Alsalameh, Sulaiman
    Makhzoum, Tariq
    Adeeb, Salma
    Al-Kattan, Khaled
    Yaqinuddin, Ahmed
    [J]. LIFE-BASEL, 2023, 13 (06):
  • [7] Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
    Cotter, Thomas G.
    Rinella, Mary
    [J]. GASTROENTEROLOGY, 2020, 158 (07) : 1851 - 1864
  • [8] Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
    Duell, P. Barton
    Welty, Francine K.
    Miller, Michael
    Chait, Alan
    Hammond, Gmerice
    Ahmad, Zahid
    Cohen, David E.
    Horton, Jay D.
    Pressman, Gregg S.
    Toth, Peter P.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (06) : E168 - E185
  • [9] A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
    Emdin, Connor A.
    Haas, Mary E.
    Khera, Amit, V
    Aragam, Krishna
    Chaffin, Mark
    Klarin, Derek
    Hindy, George
    Jiang, Lan
    Wei, Wei-Qi
    Feng, Qiping
    Karjalainen, Juha
    Havulinna, Aki
    Kiiskinen, Tuomo
    Bick, Alexander
    Ardissino, Diego
    Wilson, James G.
    Schunkert, Heribert
    McPherson, Ruth
    Watkins, Hugh
    Elosua, Roberto
    Bown, Matthew J.
    Samani, Nilesh J.
    Baber, Usman
    Erdmann, Jeanette
    Gupta, Namrata
    Danesh, John
    Saleheen, Danish
    Chang, Kyong-Mi
    Vujkovic, Marijana
    Voight, Ben
    Damrauer, Scott
    Lynch, Julie
    Kaplan, David
    Serper, Marina
    Tsao, Philip
    Mercader, Josep
    Hanis, Craig
    Daly, Mark
    Denny, Joshua
    Gabriel, Stacey
    Kathiresan, Sekar
    [J]. PLOS GENETICS, 2020, 16 (04):
  • [10] Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
    Eslam, Mohammed
    George, Jacob
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (01) : 40 - 52